157 related articles for article (PubMed ID: 21482037)
1. [Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
Classe JM; Cerato E; Boursier C; Dauplat J; Pomel C; Villet R; Cuisenier J; Lorimier G; Rodier JF; Mathevet P; Houvenaeghel G; Leveque J; Lécuru F
J Gynecol Obstet Biol Reprod (Paris); 2011 May; 40(3):201-4. PubMed ID: 21482037
[TBL] [Abstract][Full Text] [Related]
2. [Management of retroperitoneal lymphadenectomy in advanced epithelial ovarian cancer].
Jaffré I; Bordes V; Dejode M; Dravet F; Classe JM
Bull Cancer; 2010 Jan; 97(1):65-71. PubMed ID: 19995689
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
[TBL] [Abstract][Full Text] [Related]
4. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
5. Management of retroperitoneal lymph nodes in the treatment of ovarian cancer.
Ushijima K
Int J Clin Oncol; 2007 Jun; 12(3):181-6. PubMed ID: 17566840
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
Spirtos NM; Gross GM; Freddo JL; Ballon SC
Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
[TBL] [Abstract][Full Text] [Related]
7. [Retroperitoneal lymph node metastasis in patients with ovarian cancer].
Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072
[TBL] [Abstract][Full Text] [Related]
8. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
[TBL] [Abstract][Full Text] [Related]
9. Update on lymphadenectomy in early and advanced ovarian cancer.
Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
[TBL] [Abstract][Full Text] [Related]
10. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
11. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
[TBL] [Abstract][Full Text] [Related]
13. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
du Bois A; Reuss A; Harter P; Pujade-Lauraine E; Ray-Coquard I; Pfisterer J; ;
J Clin Oncol; 2010 Apr; 28(10):1733-9. PubMed ID: 20194855
[TBL] [Abstract][Full Text] [Related]
14. Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Morice P; Pautier P; Lhommé C; Castaigne D
J Natl Cancer Inst; 2005 Nov; 97(21):1620-1; author reply 1621-3. PubMed ID: 16264185
[No Abstract] [Full Text] [Related]
15. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
Salet-Lizée D; Alsary S
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
[TBL] [Abstract][Full Text] [Related]
16. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Aletti GD; Dowdy S; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
[TBL] [Abstract][Full Text] [Related]
17. Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Querleu D; Ferron G
J Natl Cancer Inst; 2005 Nov; 97(21):1621; author reply 1621-3. PubMed ID: 16264186
[No Abstract] [Full Text] [Related]
18. [Node clearance in ovarian cancer].
Villet R; Salet-Lizee D
Bull Acad Natl Med; 2010 Jan; 194(1):39-49; discussion 49-50. PubMed ID: 20669558
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy in ovarian cancer: standard of care or unnecessary risk.
Trimbos JB
Curr Opin Oncol; 2011 Sep; 23(5):507-11. PubMed ID: 21602676
[TBL] [Abstract][Full Text] [Related]
20. [A rational treatment of stage I epithelial ovarian cancer].
Wang W; Huo R
Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
